# Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section

> **NCT02936661** · PHASE4 · UNKNOWN · sponsor: **Shanghai First Maternity and Infant Hospital** · enrollment: 6700 (estimated)

## Conditions studied

- Postpartum Hemorrhage， Cesarean Section

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02936661
- **Lead sponsor:** Shanghai First Maternity and Infant Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 6700 (ESTIMATED)
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936661, "Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02936661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*